ArticleActa oncologica (Stockholm, Sweden)2025

Long-term survival of participants in the PASART-1 and PASART-2 trials of neo-adjuvant pazopanib and radiotherapy in soft tissue sarcoma.

Bauke H G Van Riet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.